The Company’s policy is to assess goodwill and indefinite-lived intangible assets for impairment annually as of April 1, with more frequent assessments if events or changes in circumstances indicate a given asset might be impaired. For the three months ended March 31, 2026, the Company considered qualitative and quantitative factors to determine whether any events or changes in circumstances had resulted in a more likely than not impairment of any of its goodwill or indefinite-lived intangible assets during the course of the quarter, and concluded there were no such indicators.


(in millions)	Connected Technology Solutions		Essential Dental Solutions		Orthodontic and Implant Solutions		Wellspect Healthcare		Total






















Balance at December 31, 2025
Goodwill	$	291	$	860	$	1,298	$	288	$	2,737
Accumulated impairment losses	(291)		—		(1,298)		—		(1,589)
Goodwill, net at December 31, 2025	—		860		—		288		1,148
Translation	—		(3)		—		(3)		(6)
Impairment	—		—		—		—		—
Goodwill, net at March 31, 2026	$	—	$	857	$	—	$	285	$	1,142

Accumulated impairment losses at March 31, 2026	(291)		—		(1,298)		—		(1,589)


	March 31, 2026						December 31, 2025
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount

Developed technology and patents	$	1,763	$	(1,340)	$	423	$	1,783	$	(1,334)	$	449
Trade names and trademarks	84		(79)		5		84		(79)		5
Licensing agreements	42		(30)		12		42		(29)		13
Customer relationships	1,089		(857)		232		1,098		(847)		251
Total definite-lived	2,978		(2,306)		672		3,007		(2,289)		718

Indefinite-lived trade names and trademarks	$	247	$	—	$	247	$	251	$	—	$	251
In-process R&D	5		—		5		5		—		5
Total indefinite-lived	252		—		252		256		—		256

Total identifiable intangible assets	$	3,230	$	(2,306)	$	924	$	3,263	$	(2,289)	$	974